21 Result(s)
-
Reference Work Entry In depth
Immunology of Melanoma
Historically, the basis of cancer immunology comes from observations of therapy for cancer dating back to antiquity indicating that the immune system can recognize and reject cancers. Ancient Eastern and Weste...
-
Living Reference Work Entry In depth
Immunology of Melanoma
Historically, the basis of cancer immunology comes from observations of therapy for cancer dating back to antiquity indicating that the immune system can recognize and reject cancers. Ancient Eastern and Weste...
-
Article
Open Access31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one
-
Article
Open AccessA Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers
-
Article
Open AccessDiversity of mutated antigen recognition by tumor infiltrating lymphocytes from patients with metastatic melanoma
-
Article
Open AccessSelection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
-
Article
Open AccessDiscovery and characterization of an immunogenic neoantigen in a patient with metastatic triple negative breast cancer
-
Article
Open AccessIdentification of mutation-specific tumor infiltrating lymphocytes from metastatic ovarian cancer
-
Article
Open AccessPersonalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
-
Article
Open AccessUnique neoantigens expressed by melanomas and common epithelial cancers presented by multiple HLA alleles can be efficiently identified utilizing peptide prediction algorithms
-
Article
Open AccessHigh frequency CD8+PD-1+ TCR clonotypes isolated from fresh melanomas display anti-tumor activity
-
Article
Open AccessAdoptively transferred tumor-infiltrating T cells target somatic cancer mutations in a human papillomavirus+ cancer patient with complete tumor regression
-
Article
Open AccessStudy and characterization of mutated antigen specific T cells isolated from fresh tumor and peripheral lymphocytes in cancer patients
-
Article
Open AccessTetramer based approach for efficient identification and isolation of neo-antigen specific CD8 T cells from peripheral blood (PBL) of patients with metastatic cancers
-
Article
Open AccessTarget discovery for T cell therapy: next steps to advance Immunotherapies
Investigators from academia and industry gathered on August 14, 2014, in Boston at the Inaugural ImVacS conference entitled “Target Discovery for T Cell Therapy: Next Step to Advance Immunotherapies”. Novel ta...
-
Article
Open AccessToward cell transfer immunotherapy against patient-specific mutations in gastrointestinal cancers
-
Article
Open AccessIndividual cultures of melanoma tumor infiltrating lymphocytes possess distinct patterns of reactivity with mutated antigens identified by whole exome sequencing of autologous tumors
-
Article
Open AccessMelanoma-associated B cells are distinct from peripheral blood-derived B cells, and may serve as a source of tumor-targeting antibodies
-
Article
Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression
The therapeutic use of T cell receptor (TCR)-transduced peripheral blood lymphocytes (PBL) targeting tumor-associated antigens is emerging as a promising investigational treatment for patients with cancer. Ini...
-
Article
A listing of human tumor antigens recognized by T cells
